Waters Corporation EV/EBITDA

EV/EBITDA of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBITDA growth rates and interactive chart. EV/EBITDA is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA). The EV/EBITDA ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBITDA compared to a stock’s historical average or industry can indicate undervaluation.


Highlights and Quick Summary

Current EV/EBITDA of Waters Corporation is 20.96 (as of December 30, 2020)
  • EV/EBITDA for the quarter ending December 30, 2020 was 20.96 (a 16.71% increase compared to previous quarter)
  • Year-over-year quarterly EV/EBITDA increased by 25.2%
  • Annual EV/EBITDA for 2020 was 20.96 (a -0.11% decrease from previous year)
  • Annual EV/EBITDA for 2019 was 20.98 (a 27.67% increase from previous year)
  • Annual EV/EBITDA for 2018 was 16.43 (a -10.59% decrease from previous year)
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBITDA of Waters Corporation

Most recent EV/EBITDAof WAT including historical data for past 10 years.

Interactive Chart of EV/EBITDA of Waters Corporation

Waters Corporation EV/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 20.96 17.96 16.64 16.74 20.96
2019 20.98 19.04 18.9 21.98 20.98
2018 16.43 16.64 17.0 17.7 16.43
2017 18.38 17.48 18.07 15.39 18.38
2016 13.74 16.93 15.42 15.07 13.74
2015 15.48 13.63 14.83 14.75 15.48
2014 14.2 12.3 13.77 14.62 14.2
2013 13.28 14.76 14.22 12.99 13.28
2012 12.34 11.31 10.65 13.12 12.34
2011 10.62 10.97 15.07 13.64 10.62
2010 13.53 13.01 12.4 13.53

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.